CTOs on the Move

Diversified Group Administrators

www.dgatpa.com

 
Diversified Group Administrators is a Harrisburg, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.dgatpa.com
  • 6345 Flank Dr Ste 400
    Harrisburg, PA USA 17112
  • Phone: 717.652.8040

Executives

Name Title Contact Details

Similar Companies

Valu-med Pharmacy Inc

Valu-med Pharmacy Inc is a Dalton, GA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

ACR Health

Opening Doors to Create Healthy Communities

Deborah Heart and Lung Center

Deborah Heart and Lung Center was established in 1922 as a tuberculosis sanitarium and pulmonary center. Legend has it that Deborah's rural Burlington County location was the key to recovery because of its therapeutic Jersey pine barren air.

TherOx

TherOx, Inc. (TherOx) is a private, venture-financed medical device company based in Irvine, California, dedicated to elevating the standard of care for treatment of heart attack patients. A heart attack is caused when an artery in the heart becomes blocked. Current treatment of heart attack is to reestablish blood flow in the blocked artery as quickly as possible. Typically, this is done with a combination of medication and a percutaneous coronary intervention (PCI) which may include the placement of a (intracoronary) stent. PCI successfully restores blood flow, but damage to the patient’s heart remains. Blood flow in the microvasculature downstream from the blockage is compromised, and critical heart muscle tissue is damaged – or infarcted – due to oxygen deprivation brought on by the heart attack. The intent of SuperSaturated Oxygen (SSO2) Therapy from TherOx is to salvage damaged heart tissue by placing a high concentration of oxygen (~760 – 1,000 mmHg, or 5 – 7 times normal levels) into the patient’s blood plasma and delivering it directly to the area impacted by the heart attack. SSO2 Therapy serves as a complement to PCI and stenting. Immediately following the interventional procedure, proprietary technology from TherOx mixes a pre-specified concentration of “SuperOxygenated” saline solution with the patient’s blood to produce SuperOxygenated blood. The SuperOxygenated blood is then delivered through a catheter to the oxygen deficient tissue. Company research has confirmed in clinical studies that SuperSaturated Oxygen Therapy has the potential to reverse ischemia and may resuscitate tissue that may otherwise die. SSO2 Therapy circulates the patient`s own blood via the existing arterial access site used for the stenting procedure. Thus, no new access site is required. The TherOx DownStream System and DownStream Cartridge bear the CE Mark but are not available for commercial distribution in the EU at this time.

Parker Health

Parker Health is a Mexican American founded company; a powerful global agent of change, driven by minority-led leadership, diversity, and innovation. Our mission is resolute: to advance healthcare and technology into the next century by simplifying complexities and realizing the potential of digital health innovation. At the core of our approach is the groundbreaking Parker EHR – a revolutionary Electronic Health Records Management System™ that redefines interoperability, accessibility, and compliance. This innovation empowers patients, healthcare providers, systems, governments, researchers, and payors through a seamless cloud-based architecture that harmonizes patient-centric data, diagnostics, outcomes, care protocols, practitioner engagement, and more. Headquartered in Washington, DC, Parker Health signifies a global catalyst for transformation, rewriting the rules of healthcare through innovative solutions that forge a brighter future.